General Announcement for PLC

20/05/2021

AGREEMENT WITH TWO CONTRACT MANUFACTURERS IN CHINA FOR PRODUCTION OF SPUTNIK V VACCINES ("AGREEMENT(S)")

UCREST BERHAD

Type Reply to Query
Reply to Bursa Malaysia's Query Letter - Reference ID IQL-20052021-00002
Subject AGREEMENT WITH TWO CONTRACT MANUFACTURERS IN CHINA FOR PRODUCTION OF SPUTNIK V VACCINES ("AGREEMENT(S)")
Description
REPLY TO QUERY FROM BURSA MALAYSIA SECURITIES BERHAD ("BURSA SECURITIES") DATED 20 MAY 2021
Query Letter Contents

We refer to your Company’s announcement dated 19 May 2021, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-

1) The date of commencement of each Agreement.
2) Whether the Agreements are subject to renewal, and if yes, the details of such renewal.
3) The value of the 312 million to 960 million doses of Sputnik V vaccines to be purchased by the Russian Direct Investment Fund.
4) The name of the contract manufacturers.
5) The total capital and investment outlay required to be committed by UCrest Berhad (“UCrest”) in connection with the Agreements, the source(s) of funding and the breakdown thereof.

6) The relevant regulatory approvals, permits and/or licenses required to be obtained by UCrest in connection with the Agreements. To also state whether UCrest has secured any of these regulatory approvals, permits and/or licences, and the relevant dates of application and approval.

Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.

 

Yours faithfully,
Listing, 
Regulation

Cc : Market Surveillance Dept. , Securities Commission (via fax)

Please refer to the attachment below for the reply to the query letter from Bursa Malaysia Securities Berhad.

 

This announcement is dated 20 May 2021.



Please refer attachment below.



Announcement Info

Company Name UCREST BERHAD
Stock Name UCREST
Date Announced 20 May 2021
Category General Announcement for PLC
Reference Number GA1-20052021-00094


Related Announcements for UCREST
Date Title
20/07/2022 OTHERS UCREST BERHAD ("UCREST" OR "THE COMPANY") - SERVICE LEVEL AGREEMENT WITH MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD
23/05/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
14/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
03/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING UCREST BERHAD ("UCREST") PRIVATE PLACEMENT OF NEW ORDINARY SHARES IN UCREST, PURSUANT TO THE GENERAL MANDATE OBTAINED FROM THE COMPANY'S SHAREHOLDERS ("PRIVATE PLACEMENT")
23/02/2022 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") - MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
30/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") ("MOU") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF ("MSA")
26/11/2021 (I) MEMORANDUM OF UNDERSTANDING WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") (II) MASTER SERVICE AGREEMENT BETWEEN UCREST BERHAD'S ("UCREST") WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED, AND LIMITED LIABILITY COMPANY HUMAN VACCINE, A WHOLLY OWNED SUBSIDIARY OF RDIF
24/11/2021 MEMORANDUM OF UNDERSTANDING UCREST BERHAD ("UCREST" OR "THE COMPANY") - MEMORANDUM OF UNDERSTANDING ("MOU") WITH RUSSIAN DIRECT INVESTMENT FUND ("RDIF") - MASTER SERVICE AGREEMENT ("MSA") BETWEEN UCREST'S WHOLLY OWNED SUBSIDIARY, UCREST TECHNOLOGY LIMITED ("UTL") AND LIMITED LIABILITY COMPANY HUMAN VACCINE ("HUMAN VACCINE"), A WHOLLY OWNED SUBSIDIARY OF RDIF
29/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : DEALINGS DURING CLOSED PERIOD
01/10/2021 DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : INTENTION TO DEAL DURING CLOSED PERIOD